Microread Genetics

Beijing Microread Genetics Co., Ltd. (hereinafter referred to as "Microread Genetics") was officially operated in 2009, which is a life science institution integrating R & D, production and operation. It is committed to the commercialization of genetic detection technology and focuses on the "gold standard" sequencing technology platforms based on capillary electrophoresis (CE) technology. Through refined production process and quality verification, we have developed a series of accurate, fast, simple and economic detection reagents, which are applied in clinical, forensic, industrial production, agriculture and animal husbandry fields at the same time.

Microread Genetics is headquartered in Zhongguangcun Science and Technology Park, Haidian District, Beijing. Two GMP factories equipped with advanced facilities are based in Beijing and Suzhou, with a total area of over 3,000 square meters. They are capable of producing Class I, II, and III in vitro diagnostic reagents as well as products for forensic usage with an annual production capacity of 10 million tests, making us one of the top manufactories in this industry. Microread Genetics is headquartered in Zhongguangcun Science and Technology Park, Haidian District, Beijing. Two GMP factories equipped with advanced facilities are based in Beijing and Suzhou with a total area of over 3,000 square meters, and a number of technical service centers are set across the country to timely respond to customer needs. In 2018, Microread Genetics established an overseas subsidiary in Kazakhstan and began to actively expand its overseas business.

Microread Genetics have obtained various certifications, like national high-tech enterprise, national public safety product and ISO quality management system certifications. We also obtained Class III medical device production license and owned a independent third-party clinical laboratory, with dozens of invention patents and software copyrights. Microread Genetics has received multuple national, provincial and municipal project fundings. At present, it has nearly 300 employees and the annual gross income is over 100 million CNY.

Microread Genetics becomes an industry leader in forensic science industry with its self-developed autosomal and sex-chromosome STR amplification kits with an annual sales of millions tests. The newly developed automatic DNA extraction machine&kit, sample keeper, and analysis software make Microread Genetics a supplier of integrated solutions for forensic science applications. To keep pace with the technical breakthroughs, we're also developing services and products like mitochondria sequencing, and NGS kit for forensic applications. We believe these new techniques will bring our forensic customers more powerful tools to solve their complex problems.

In the clinical field, Microread Genetics masters a core technology - rapid multiplex amplification system, making clinical molecular tests fast and easy-to-use. Within a single tube, multiple genetic markers could be detected within 20 min manual operation. And the entire process takes 2.5 hours, capable of direct amplification of blood card without DNA extraction. Our integrated solutions consist of products covering various aspects of clinical applications, including reproductive diseases screening, individualized diagnosis and treatment, and medication guidance.The series products are used to create overall solutions in related fields.

Microread Genetics becomes an industry leader in forensic science industry with its self-developed autosomal and sex-chromosome STR amplification kits with an annual sales of millions tests. The newly developed automatic DNA extraction machine&kit, sample keeper, and analysis software make Microread Genetics a supplier of integrated solutions for forensic science applications. To keep pace with the technical breakthroughs, we're also developing services and products like mitochondria sequencing, and NGS kit for forensic applications. We believe these new techniques will bring our forensic customers more powerful tools to solve their complex problems.

Microread Genetics is headquartered in Zhongguancun Science and Technology Park, 

An independent clinical lab in Guangzhou

Cooperation Pattern Introduction

In terms of cooperation, the company adheres to the principle of "openness and all-win" and is willing to cooperate with various types of enterprises or institutions in the industry. We could not only provide these genotyping kits above, but also, we can cooperate with each other through other means. Taking cooperation with hospitals as an example, we can carry out the following types of cooperation: We can work with hospitals and use the platforms they have to carry out relevant genetic testing services. If there is no laboratory in the hospital, we can invest in a DNA laboratory to perform the above tests.

These tests are guidance for disease diagnosis and treatment. They have been applied on a large population in China and they are proved to be mature technologies. Taking Down's syndrome screening as an example, in china, there are more than 3 million people taking the test each year, with the cost of about 1,000 Yuan per test. In other countries, the test also has a rigid demand. If we can localize this service, we can not only greatly shorten the inspection time, but also reduce the detection cost. All other tests face the similar situations. To carry out genetic tests in the local hospitals can meet the market demand effectively, as well as produce huge economic and social benefits.

We are looking forward to cooperating, growing and developing with you sincerely.

（如无法正常观看视频请更新flash插件）